Intestinal fructose metabolism triggers a glucagon‐like peptide‐1–β‐cell axis to prevent post‐fructose hyperglycaemia
The Journal of Physiology · 2025
DOI: 10.1113/jp289067 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physiology, 2025. Verfasst von Naoya Murao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, School of Medicine, Toyoake, Japan. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Fructose, Hyperglycemia, Insulin-Secreting Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Association for Diabetes Education and Care, Daiwa Securities Health Foundation.
Abstract (Originalsprache)
Fructose ingestion increases circulating glucagon‐like peptide‐1 (GLP‐1) and insulin, yet the specific contributions of these hormonal responses to glycaemic control remain incompletely defined. We hypothesised that fructose metabolism in intestinal L‐cells triggers GLP‐1 secretion, which then potentiates insulin secretion and counteracts fructose‐induced hyperglycaemia. To test this hypothesis, we systematically characterised metabolic responses across multiple mouse strains after 24 h ad libitum fructose ingestion. In both lean (NSY.B6‐ a / a ) and obese diabetic (NSY.B6‐ A y / a ) mice, fructose elevated plasma insulin, GLP‐1 and glucose‐dependent insulinotropic polypeptide (GIP). The insulin response was preserved in GIP receptor‐deficient mice ( Gipr −/− ) but was abolished in proglucagon‐deficient mice ( Gcg −/− ) by pharmacological GLP‐1 receptor antagonism, indicating a requirement for GLP‐1, but not GIP. Across strains, fructose‐induced insulin response correlated with attenuation of post‐fructose glycaemia, consistent with insulin being essential for suppressing fructose‐induced hyperglycaemia. To explore the mechanism underlying fructose‐induced GLP‐1 secretion, we combined ATP‐sensitive potassium channel‐deficient mice ( Kcnj11 −/− ), the GLUTag L‐cell line, and metabolic tracing of 13 C‐labelled fructose in freshly isolated intestinal crypts. These complementary approaches support a model in which fructolysis increases the ATP/ADP ratio in L‐cells, closes K ATP channels and stimulates GLP‐1 secretion. In obese diabetic mice, increased fructolytic flux and a higher ATP/ADP ratio were associated with elevated GLP‐1 levels, further corroborating this model. Collectively, our findings indicate that intestinal fructose metabolism drives GLP‐1 secretion required to potentiate insulin secretion, thereby establishing a gut–pancreas axis that counter‐regulates fructose‐induced hyperglycaemia. image Key points Fructose ingestion acutely increases plasma insulin levels, but the underlying mechanisms and physiological significance remain elusive. Our study demonstrates that short‐term (24 h) fructose ingestion in mice elevates both insulin and glucagon‐like peptide 1 (GLP‐1) levels in the blood, with the plasma insulin response being GLP‐1‐dependent. We found that fructose metabolism in intestinal L‐cells triggered GLP‐1 secretion by increasing the ATP/ADP ratio and closing ATP‐sensitive K + (K ATP ) channels. This intestinal fructose metabolism–GLP‐1–β‐cell axis plays a crucial role in preventing fructose‐induced hyperglycaemia, an effect that is compromised in obese diabetic mice. These insights highlight the previously unclear metabolic responses following short‐term fructose ingestion and their importance in glucose homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, School of Medicine, Toyoake, Japan.
- Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kyoto, Japan.
- Center for Research of Laboratory Animals and Medical Research Engineering Division for Research of Laboratory Animals, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
- Laboratory of Animal Breeding and Genetics, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
- Department of Endocrinology and Metabolism, School of Medical Sciences, University of Fukui, Fukui, Japan.
- Department of Endocrinology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.
ORCID-Profile: Naoya Murao, Yusuke Seino, Risa Morikawa, Takuya Haraguchi, Tamio Ohno, Norihide Yokoi, Norio Harada, Yoshitaka Hayashi, Yuichiro Yamada, Atsushi Suzuki
Förderung
- Japan Society for the Promotion of Science
- Japan Association for Diabetes Education and Care
- Daiwa Securities Health Foundation
- Suzuken Memorial Foundation
- Japan Diabetes Foundation
- Hori Sciences and Arts Foundation
- Manpei Suzuki Diabetes Foundation
- Fujita Health University
Zitieren
APA
Murao, N., Seino, Y., Morikawa, R., Hidaka, S., Haraguchi, T., Tomatsu, E., Habara, M., Ohno, T., Yokoi, N., Harada, N., Hayashi, Y., Yamada, Y., & Suzuki, A. (2025). Intestinal fructose metabolism triggers a glucagon‐like peptide‐1–β‐cell axis to prevent post‐fructose hyperglycaemia. The Journal of Physiology. https://doi.org/10.1113/jp289067
Vancouver
Murao N, Seino Y, Morikawa R, Hidaka S, Haraguchi T, Tomatsu E, et al. Intestinal fructose metabolism triggers a glucagon‐like peptide‐1–β‐cell axis to prevent post‐fructose hyperglycaemia. The Journal of Physiology. 2025. doi:10.1113/jp289067
BibTeX
@article{Murao2025,
author = {Murao, Naoya and Seino, Yusuke and Morikawa, Risa and Hidaka, Shihomi and Haraguchi, Takuya and Tomatsu, Eisuke and Habara, Mutsumi and Ohno, Tamio and Yokoi, Norihide and Harada, Norio and Hayashi, Yoshitaka and Yamada, Yuichiro and Suzuki, Atsushi},
title = {Intestinal fructose metabolism triggers a glucagon‐like peptide‐1–β‐cell axis to prevent post‐fructose hyperglycaemia},
journal = {The Journal of Physiology},
year = {2025},
doi = {10.1113/jp289067}
}
EUVIMED